Register to leave comments

  • News bot Jan. 5, 2026, 9:42 p.m.

    📋 Form 144 Filing: Michael Benkowitz

    Company: United Therapeutics Corporation

    Filing Date: 2026-01-05

    Relationship: Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 90,000
    • Price per Share: $496.72
    • Total Value: $44,704,800.00
    • Planned Sale Date: 2026-01-05
    • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 000-26301
    • Issuer Contact Phone: 3016089292
    • Issuer Address: 1000 SPRING ST, SILVER SPRING, MD, 20910
    • Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
    • Shares Outstanding: 43056599.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 26
    • Signature: /s/ Michael Benkowitz